Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novavax’s Vaccine Switched Manufacturing Facilities Multiple Times Prior To EUA
Jul 25 2022
•
By
Derrick Gingery
Novavax told the FDA of a manufacturing change late in the review of the EUA request for its COVID-19 vaccine . • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance